GSK Investigational Site

Syktyvkar 167904

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 2, Multiple Myeloma

Studies at this site

• Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) — Running, not enrolling
• Thiazolidinedione Intervention With Vitamin D Evaluation — Stopped early